A detailed history of Boltwood Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Boltwood Capital Management holds 2,985 shares of JNJ stock, worth $477,988. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,985
Previous 3,090 3.4%
Holding current value
$477,988
Previous $451,000 7.1%
% of portfolio
0.14%
Previous 0.14%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$145.48 - $167.38 $15,275 - $17,574
-105 Reduced 3.4%
2,985 $483,000
Q2 2024

Jul 08, 2024

SELL
$144.38 - $157.78 $2,165 - $2,366
-15 Reduced 0.48%
3,090 $451,000
Q1 2024

Apr 04, 2024

SELL
$155.22 - $162.74 $6,208 - $6,509
-40 Reduced 1.27%
3,105 $491,000
Q4 2023

Jan 05, 2024

SELL
$145.6 - $158.88 $56,056 - $61,168
-385 Reduced 10.91%
3,145 $492,000
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $28,035 - $31,406
-180 Reduced 4.85%
3,530 $549,000
Q2 2023

Jul 06, 2023

SELL
$154.35 - $166.11 $771 - $830
-5 Reduced 0.13%
3,710 $614,000
Q1 2023

Apr 03, 2023

SELL
$151.05 - $180.26 $70,993 - $84,722
-470 Reduced 11.23%
3,715 $575,000
Q4 2022

Jan 06, 2023

SELL
$160.2 - $179.79 $9,131 - $10,248
-57 Reduced 1.34%
4,185 $0
Q3 2022

Oct 04, 2022

SELL
$161.33 - $179.52 $759,864 - $845,539
-4,710 Reduced 52.61%
4,242 $693,000
Q2 2022

Jul 07, 2022

SELL
$168.19 - $186.01 $11,436 - $12,648
-68 Reduced 0.75%
8,952 $1.59 Million
Q1 2022

Apr 20, 2022

SELL
$158.14 - $179.59 $10,279 - $11,673
-65 Reduced 0.72%
9,020 $1.6 Million
Q4 2021

Jan 10, 2022

SELL
$155.93 - $173.01 $38,982 - $43,252
-250 Reduced 2.68%
9,085 $1.55 Million
Q3 2021

Oct 08, 2021

SELL
$161.5 - $179.47 $32,300 - $35,894
-200 Reduced 2.1%
9,335 $1.51 Million
Q1 2021

Apr 05, 2021

SELL
$153.07 - $170.48 $59,697 - $66,487
-390 Reduced 3.93%
9,535 $1.57 Million
Q2 2020

Jul 02, 2020

SELL
$128.81 - $155.51 $12,881 - $15,551
-100 Reduced 1.0%
9,925 $1.4 Million
Q1 2020

Apr 07, 2020

SELL
$111.14 - $153.99 $30,563 - $42,347
-275 Reduced 2.67%
10,025 $1.32 Million
Q4 2019

Jan 07, 2020

SELL
$127.5 - $146.44 $165,622 - $190,225
-1,299 Reduced 11.2%
10,300 $1.5 Million
Q3 2019

Oct 02, 2019

SELL
$126.95 - $142.14 $17,138 - $19,188
-135 Reduced 1.15%
11,599 $1.5 Million
Q1 2019

Apr 02, 2019

SELL
$125.72 - $139.79 $14,583 - $16,215
-116 Reduced 0.98%
11,734 $1.64 Million
Q4 2018

Jan 07, 2019

SELL
$122.84 - $147.84 $12,284 - $14,784
-100 Reduced 0.84%
11,850 $1.53 Million
Q2 2018

Jul 06, 2018

SELL
$119.4 - $131.76 $93,967 - $103,695
-787 Reduced 6.18%
11,950 $1.45 Million
Q1 2018

Apr 05, 2018

SELL
$125.1 - $148.14 $23,518 - $27,850
-188 Reduced 1.45%
12,737 $1.63 Million
Q4 2017

Jan 10, 2018

SELL
$131.22 - $143.62 $13,122 - $14,362
-100 Reduced 0.77%
12,925 $1.81 Million
Q3 2017

Oct 10, 2017

BUY
$129.47 - $135.38 $1.69 Million - $1.76 Million
13,025
13,025 $1.69 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Boltwood Capital Management Portfolio

Follow Boltwood Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.